Trial intelligence / Profile preview

Taclonex Ointment with Hydrogel Patch for Plaque Psoriasis

NCT00924950Phase 4Terminated

Sponsor
University of California, San Francisco
Start
Jun 2009
Primary completion
Dec 2009
Countries
1
01

Overview

A Phase 4 trial of Taclonex + Hydrogel Patch in plaque psoriasis, sponsored by University of California, San Francisco. Started Jun 2009; status: terminated.

02

Drugs

Taclonex + Hydrogel Patch
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT00924950.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00924950.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call